in a patient with AIDS. Ann Ophthalmol 90:859-872, 1983
2)Palani D, Kulandai LT, Naraharirao MH et al:Application of polymerase chain reaction-based restriction fragment length polymorphism in typing ocular rapid-growing nontuberculous mycobacterial isolates from three patients with postoperative endophthalmitis. Cornea 26:729-735, 2007
3)日本結核病学会非結核性抗酸菌症対策委員会・日本呼吸器学会感染症・結核学術部会:肺非結核性抗酸菌症化学療法に関する見解―2008暫定.結核 83:731-733,2008
complex infection with rifabutin. Arch Ophthalmol 112:1159-1165, 1994
5)Skolik S, Willermain F, Caspers LE:Rifabutin-associated panuveitis with retinal vasculitis in pulmonary tuberculosis. Ocul Immunol Inflamm 13:483-485, 2005
6)Siegal FP, Eilbott D, Burger H et al:Dose-limiting toxicity of rifabutin in AIDS-related complex:syndrome of arthralgia/arthritis. AIDS 4:433-441, 1990
complex bacteremia:a multivariate analysis. J Infect Dis 177:252-255, 1998
8)Hafner R, Bethel J, Power M et al:Tolerance and pharmacokinetic interactions of rifabutin and clarithromycin in human immunodeficiency virus-infected volunteers. Antimicrob Agents Chemother 42:631-639, 1998